0.590
0.00 (0.00%)
前收盘价格 | 0.590 |
收盘价格 | 0.585 |
成交量 | 1,290 |
平均成交量 (3个月) | 15,409 |
市值 | 90,376,192 |
预期市盈率 (P/E Forward) | 53.76 |
价格/销量 (P/S) | 47.99 |
股市价格/股市净资产 (P/B) | 0.890 |
52周波幅 | |
利润日期 | 26 Mar 2025 - 31 Mar 2025 |
营业利益率 (TTM) | -317.97% |
稀释每股收益 (EPS TTM) | -0.080 |
季度收入增长率 (YOY) | 7.80% |
总债务/股东权益 (D/E MRQ) | 80.32% |
流动比率 (MRQ) | 0.420 |
营业现金流 (OCF TTM) | -83.42 M |
杠杆自由现金流 (LFCF TTM) | -196.74 M |
资产报酬率 (ROA TTM) | -4.03% |
股东权益报酬率 (ROE TTM) | -13.14% |
市场趋势
短期 | 中期 | ||
行业 | Oil & Gas E&P (AU) | 混合的 | 混合的 |
Oil & Gas E&P (全球的) | 混合的 | 混合的 | |
股票 | RENERGEN CDI 1:1 [RLT] | - | - |
AIStockmoo 评分
分析师共识 | 0.0 |
内部交易活动 | NA |
价格波动 | 3.0 |
技术平均移动指标 | 2.5 |
技术振荡指标 | -2.5 |
平均 | 0.75 |
Renergen Ltd is an investment holding company focused on the alternative and renewable energy sectors in South Africa and sub-Saharan Africa. Its reportable segments are the Corporate Head office where all investment decisions are made; Tetra4 which explores, produces, and sells LNG in South Africa; Cryovation which has developed Cryo-VaccTM technology, and enables the safe transportation of vaccines and biologics at extremely low temperatures without the need for electrical power; and the Renergen U.S segment which assists with various fundraising and business development activities of the Group in the U.S market. The majority of the company's revenue is generated from the Tetra4 segment. |
|
部门 | Energy |
行业 | Oil & Gas E&P |
投资方式 | Small Growth |
内部持股比例 | 56.02% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合